Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups

Author:

Hojsak Iva12,Fabiano Valentina3,Pop Tudor Lucian4,Goulet Olivier5,Zuccotti Gian Vincenzo3,Çokuğraş Fugen Cullu6,Pettoello-Mantovani Massimo78,Kolaček Sanja1

Affiliation:

1. Children's Hospital Zagreb; University of Zagreb School of Medicine; Zagreb Croatia

2. School of Medicine; University J.J Strossmayer; Osijek Croatia

3. Paediatric Department; Vittore Buzzi Children's Hospital; Università degli Studi di Milano; Milan Italy

4. 2nd Paediatric Clinic; University of Medicine and Pharmacy Iuliu Hatieganu; Cluj-Napoca Romania

5. Department of Paediatric Gastroenterology, Hepatology and Nutrition; Intestinal Failure Rehabilitation Centre; National Reference Centre for Rare Digestive Diseases; APHP Necker-Enfants Malades Hospital; Paris-Descartes University; Paris France

6. Paediatric Gastroenterology, Hepatology and Nutrition; Cerrahpaşa Medical Faculty; Istanbul University; Istanbul Turkey

7. Department of Paediatrics; Scientific Institute ‘Casa Sollievo della Sofferenza’; University of Foggia; Foggia Italy

8. European Paediatric Association/Union of National European Paediatric Societies and Associations (EPA/UNEPSA); Berlin Germany

Publisher

Wiley

Subject

General Medicine,Pediatrics, Perinatology, and Child Health

Reference60 articles.

1. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics;Gibson;Nat Rev Gastroenterol Hepatol,2017

2. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic;Hill;Nat Rev Gastroenterol Hepatol,2014

3. European Paediatric Association, the Union of National European Paediatric Societies and Associations Turns 40 Years: What This European Platform Offers to Pediatricians;Gerber-Grote;J Pediatr,2017

4. Center for Drug Evaluation and Research; Center for Biologics Evaluation and Research Guidance for industry: providing clinical evidence of effectiveness for human drug and biological products 1998 http://www.fda.gov/downloads/Drugs%20/GuidanceComplianceRegulatoryInformation/Guidances/ucm078749.pdf

5. Health care utilization and expenditures associated with child care attendance: a nationally representative sample;Silverstein;Pediatrics,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3